Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionSRS Capital Advisors, Inc.
Latest Disclosed Ownership8,499 shares
Latest Disclosed Value $ 1,184,443
SRS Capital Advisors, Inc. reports 71.05% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - SRS Capital Advisors, Inc. filed a 13F-HR form disclosing ownership of 8,499 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,184,443 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 29,354 shares of Gilead Sciences, Inc.. This represents a change in shares of -71.05% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 8,499 -20,855 -71.05 1,184 -67.13 0.0334
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 29,354 -34,307 -53.89 3,603 -49.02 0.1049
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 63,661 58,541 1,143.38 7,066 1,034.19 0.1014
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 5,120 2,515 96.55 623 114.09 0.0286
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,605 668 34.49 292 63.48 0.0187
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,937 1,668 620.07 179 709.09 0.0113
2024-11-06 2024-09-30 13F GILEAD SCIENCES COM 375558103 269 60 28.71 23 57.14 0.0020
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 209 93 80.17 14 75.00 0.0014
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 116 -48 -29.27 9 -38.46 0.0009
2024-02-06 2023-12-31 13F GILEAD SCIENCES COM 375558103 164 60 57.69 13 85.71 0.0015
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 104 -13 -11.11 8 -22.22 0.0010
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 117 -41 -25.95 9 -30.77 0.0011
2023-05-16 2023-03-31 13F GILEAD SCIENCES COM 375558103 158 42 36.21 13 44.44 0.0017
2023-02-24 2022-12-31 13F GILEAD SCIENCES COM 375558103 116 15 14.85 10 50.00 0.0014
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 101 -145 -58.94 6 -60.00 0.0009
2022-08-22 2022-06-30 13F GILEAD SCIENCES COM 375558103 246 181 278.46 15 275.00 0.0023
2022-05-12 2022-03-31 13F GILEAD SCIENCES COM 375558103 65 36 124.14 4 100.00 0.0005
2022-02-08 2021-12-31 13F GILEAD SCIENCES COM 375558103 29 -152 -83.98 2 -84.62 0.0003
2021-11-05 2021-09-30 13F GILEAD SCIENCES COM 375558103 181 181 13 0.0018
2021-02-03 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -380 -100.00 0 -100.00
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 380 380 24 0.0040
2019-08-08 2019-06-30 13F GILEAD SCIENCES COM 375558103 0 -106 -100.00 0 -100.00
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 106 -349 -76.70 7 -80.00 0.0028
2018-11-05 2018-09-30 13F GILEAD SCIENCES COM 375558103 455 -1,158 -71.79 35 -69.30 0.0141
2018-08-21 2018-06-30 13F GILEAD SCIENCES INC COM COM 375558103 1,613 -121 -6.98 114 -12.31 0.0500
2018-05-14 2018-03-31 13F GILEAD SCIENCES INC COM COM 375558103 1,734 8 0.46 130 5.69 0.0675
2018-02-15 2017-12-31 13F GILEAD SCIENCES INC COM COM 375558103 1,726 -11 -0.63 123 -12.14 0.0534
2017-11-15 2017-09-30 13F GILEAD SCIENCES INC COM COM 375558103 1,737 -95 -5.19 140 8.53 0.0673
2017-08-14 2017-06-30 13F GILEAD SCIENCES INC COM COM 375558103 1,832 798 77.18 129 84.29 0.0617
2017-05-11 2017-03-31 13F GILEAD SCIENCES INC COM COM 375558103 1,034 323 45.43 70 37.25 0.0337
2017-02-14 2016-12-31 13F GILEAD SCIENCES INC COM COM 375558103 711 711 51 0.0255
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.